ASGCT 19th Annual Meeting
Washington, D.C.
May 4-7, 2016

PeriphaGen will be presenting a poster entitled "PGN-503, a Herpes Simplex Virus Based Vector Expressing Neurotrophin-3, Prevents and Reverses Neuropathy in a Mouse Model of Paclitaxel-Induced Peripheral Neuropathy" at the 19th annual meeting of the American Society of Gene & Cell Therapy.


PeriphaGen believes in the importance of disseminating information and sharing what we are doing as a company. Check back here to see where we will be presenting our latest findings.


Copyright (C) 2016 | PeriphaGen, Inc; All rights reserved

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon